Amylyx Pharmaceuticals, Inc. (AMLX)
31.62
-0.47
(-1.46%)
USD |
NASDAQ |
Sep 11, 16:00
31.63
+0.01
(+0.03%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price to Book Value : 14.72 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 14.72 |
| September 10, 2026 | 14.94 |
| September 09, 2026 | 15.09 |
| September 08, 2026 | 15.78 |
| September 04, 2026 | 15.88 |
| September 03, 2026 | 15.81 |
| September 02, 2026 | 16.06 |
| September 01, 2026 | 15.74 |
| August 31, 2026 | 15.72 |
| August 28, 2026 | 16.18 |
| August 27, 2026 | 17.31 |
| August 26, 2026 | 17.27 |
| August 25, 2026 | 17.44 |
| August 24, 2026 | 17.76 |
| August 21, 2026 | 18.00 |
| August 20, 2026 | 18.47 |
| August 19, 2026 | 17.97 |
| August 18, 2026 | 16.35 |
| August 17, 2026 | 9.979 |
| August 14, 2026 | 10.07 |
| August 13, 2026 | 10.47 |
| August 12, 2026 | 10.87 |
| August 11, 2026 | 11.00 |
| August 10, 2026 | 10.56 |
| August 07, 2026 | 10.63 |
| Date | Value |
|---|---|
| August 06, 2026 | 11.26 |
| August 05, 2026 | 10.17 |
| August 04, 2026 | 10.18 |
| August 03, 2026 | 9.392 |
| July 31, 2026 | 9.457 |
| July 30, 2026 | 9.662 |
| July 29, 2026 | 9.187 |
| July 28, 2026 | 9.104 |
| July 27, 2026 | 9.076 |
| July 24, 2026 | 8.573 |
| July 23, 2026 | 8.191 |
| July 22, 2026 | 8.242 |
| July 21, 2026 | 8.615 |
| July 20, 2026 | 8.126 |
| July 17, 2026 | 8.265 |
| July 16, 2026 | 7.925 |
| July 15, 2026 | 8.279 |
| July 14, 2026 | 8.475 |
| July 13, 2026 | 8.107 |
| July 10, 2026 | 8.275 |
| July 09, 2026 | 8.559 |
| July 08, 2026 | 8.326 |
| July 07, 2026 | 8.461 |
| July 06, 2026 | 8.368 |
| July 02, 2026 | 8.508 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.854 |
| Eli Lilly & Co. | 31.01 |
| Merck & Co., Inc. | 8.473 |
| EyePoint, Inc. | 2.160 |
| Bristol Myers Squibb Co. | 5.825 |
Price to Book Value Related Metrics
| Price | 31.62 |
| Earnings Yield | -4.53% |
| Market Cap | 3.521B |